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Membrane cofactor protein (MCP) of complement is a C3b/C4b binding glyco-
protein (1) that possesses cofactor activity for the Factor 1-mediated proteolysis of
C3b and C4b (2). MCP has a wide tissue distribution (1, 3-5), and its physiologic
role may be to protect autologous tissue from complement-mediated damage (6-7).
Our laboratory has recently cloned and sequenced a full-length MCP cDNA (8).
Sequence analysis demonstrated that MCP contains at its NH2 terminus four copies
of the 60 amino acid cysteine rich short consensus repeats (SCRs) which are also
present in the other members of the C3b/C4b binding gene family of regulatory
and receptor proteins (reviewed in references 9 and 10). Using in situ hybridization,
the structural gene for MCP was localized to human chromosome 1, bands lg31-41
(8). Structural genes for C4 binding protein (C4bp), Factor H, the C3b/C4b receptor
or complement receptor type one (CRI), C3d/EBV receptor or complement receptor
type two (CR2), and decay-accelerating factor (DAF) have been localized to the same
region of human chromosome 1 (11-14). Two recent reports have shown that genes
encoding CRI, CR2, DAF, and C4bp are aligned on a 750-800 kb DNA segment
within this regulator ofcomplement activation (RCA) gene cluster (15, 16). The order
for these genes within this cluster was shown to be CR1-CR2-DAFC4bp (15, 16).
In the present report we demonstrate that the gene for MCP is on the same 1,250-
kb Not I fragment that also contains CRl, CR2, DAF, and C4bp and maps within
100 kb of the 3' end of the CR1 gene.
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Materials and Methods
BriefDefinitive Report
Preparation ofDNA.
￿
High molecular weight genomic DNA was prepared from a human
promyelocytic cell line (HL-60) cells according to the method of Kenwrick et al. (17). Briefly,
freshly grown mammalian cells were harvested, pelleted, and washed two times with PBS
(0.15 M NaCl, 1.92 mM NaH2PO4, 8.7 mM K2HPO2 , pH 7.4). The cells, suspended in PBS
at 2 x 107 cells/ml, were mixed with an equal volume of 1% low gel agarose (Bethesda Re-
search Laboratories, Gaithersburg, MD). The mixture was cooled to 50°C and immediately
poured to a depth of 2 mm in an ice cooled sterile Petri dish. When set, the agarose was
cut into blocks o£ 2 x 5 x 10 mm. These blocks were then incubated in ESP (0.5 M EDTA,
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pH 9.0, 1% sodium lauroylysarcosine, 1 mg/ml proteinase K [Boehringer Mannheim Bio-
chemicals, Indianapolis, IN]) for 2 d at 50°C with gentle shaking. The samples were stored
in ESP at 4°C.
Restriction Enzyme Digestion and Analysis by Pulsed Field Gel Electrophoresis (PFGE).
￿
Before
digestion, the agarose plugs containing ti5 l~g of DNA were washed twice with 1 ml of 1 mM
PMSF in TE (10 mM Tris-HCI [pH 7.4], 0.1 mM EDTA) by slow rotation at room tempera-
ture for 90 min. This was followed by three washes in 1 ml TE at room temperature.
Restriction enzyme digestions were carried out according to the supplier's recommenda-
tions (New England Biolabs, Beverly, MA). 100 U of restriction endonucleases were used
in a final volume of 0.5 ml. Samples were digested for 8 h at the recommended temperature.
Reactions requiring more than one enzyme were conducted in two stages, using the enzyme
with activity in the lower salt concentration or temperature first.
After the enzymatic digestion DNA blocks were washed for 2 h at 50°C in ES followed
by 2 h of treatment with proteinase K (1 mg/ml in ES). The restriction fragments were sepa-
rated either by othogonal field alternation gel electrophoresis (OFAGE) (18) or by field inver-
sion gel electrophoresis (FIGE) (19).
For OFAGE, a 1.5% agarose gel (10.5 x 10.5 x 0.4 cm) in 0.5 x TBE (1 x TBE = 90
mM Tris base, 90 mM boric acid, 1 mM EDTA) was used. Electrophoresis was performed
for 22 h at 14°C using a switch interval of 15, 35, or 50 s with an applied voltage of 300 V.
For FIGE, a 23 cm long, 15 cm wide, and 0.5 cm thick gel containing 1% agarose was
cast and run in 0.5 x TBE. To create switching-interval ramps, a PP1-100 microcomputer
(MJ Research, Inc., Cambridge, MA) was used. A switching-interval ramp in which the for-
ward migration interval varied linearly from 10 s at t = 0 h to 60 s at t = 12 h with a constant
reverse interval of 5 s was used for separations between 260 and 700 kb. To achieve separa-
tions above 700 and up to 1,500 kb, the forward migration interval was varied linearly from
9 s at t = 0 h to 60 s at t = 12 h and a ratio of 3:1 between forward and reverse intervals
was used (19) . Electrophoresis was performed for 24 h at 260 V at WC. Intact yeast chromo-
somes (Saccharomyces cerevisiae, strain AB972) prepared in agarose blocks (20) and tan-
demly annealed XDNA concatemers with a monomer length of 48.5 kb were used as molec-
ular weight markers (18).
Transfer and Hybridization.
￿
After ethidium bromide staining, the gels were treated with
0.25 M HCl twice for 15 min according to Maniatis et al. (21). DNA was then transferred
to nitrocellulose according to the method of Smith and Summers (22). DNA probes were
labeled with 12P by the random oligonucleotide priming method, as described by Feinberg
and Vogelstein (23), to a specific activity of at least 2 x 108 cpm/t+g. Hybridization and high
stringency washing (0.2 x SSC, 0.10 1o SDS, 65°C) were carried out following standard proce-
dures (21). Autoradiography was done for 1-5 d using Kodak RX-Omat films at -80°C.
Filters were stripped of a probe by washing in 0.4 M NaOH at 45°C for 30 min followed
by washing in 0.2 M Tris HCl (pH 7.5), 0.1 x SSC, 1% SDS at 45°C for 30 min.
Probes.
￿
cDNA probes for CRl (24, 25), DAF (26), MCP (8) and leukocyte common an-
tigen or T-200 (27) have been described. The CRl probe is 980 by in length, extending from
nucleotide 422 to nucleotide 1402, covering the area from 3rd to the 7th SCR. The DAF
probe is a full-length 1.9 kb cDNA probe whose sequence is described by Medof et al . (26).
The MCP probe is also a full-length 1.5-kb cDNA probe whose sequence is described by
Lublin et al. (8). The probe used for human leukocyte common antigen (LCA) is 1.8 kb
in length and is described in reference 27. CR2 probe is 1.45-kb Eco RI fragment of a CR2
cDNA clone (Holers, V. M., unpublished data).
Results and Discussion
Probes for CRl, DAF, and MCP hybridized to a common fragment of -1,250
kb of Not 1-digested DNA (Fig. 1 a). Two recent reports have shown that the genes
for CR1, CR2, DAF, and C4bp are present on a common Not I fragment of -1,250
kb (15, 16). Our results confirm these observations and place the MCP gene on this
same fragment. Digestion of DNA with Mlu I gave two fragments of 800 and 550BORA ET AL .
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FIGURE 1 .
￿
Southern blot analyses ofgenomicDNA digests separated byPFGE . Yeast chromosomes
and, in some cases, X phage concatemers were employed as size markers . Hybridization at the
top of the gel in some of these blots may represent undigested DNA. (a) Fragments generated
by Not 1 . Southern blot was sequentially hybridized with CRl, DAF, and MCP probes . CRl,
DAF and MCP probes identify a common fragment of 1,250 kb. (b) Fragments generated by
Not IandMlu 1 . Autoradiograms were obtained from a single filter hybridized sequentially with
the probes shown . A 470-kb fragment hybridizes to all three probes . (c) Fragments generated
by Sfi I . This blot was sequentially hybridized with CRl, MCPandCR2 probes . CRI andMCP
probes recognize a 380 fragment . CR2 identifies a fragment of 70 kb. The apparent hybridiza-
tion between 50 and 150 kb in the MCP lane may represent partially degraded DNA. (d) Frag-
ments generatedby Sfi I and Sal I . CRI probe hybridizes to a280-kb fragment while MCP hy-
bridizes to a 100-kb piece . (e) Fragments generated by Sal I . Sequential hybridization with CRI
andMCP probes . CRI probe identifies a restriction fragment of 630 kb while MCP probe hy-
bridizes to a 180-kb fragment. (/) Fragments generated with Mlu I and Sal I . CR1 hybridizes
to a320-kb fragment andMCPto a 180-kb fragment. (g) Fragments generated by Sac II . MCP
hybridizes to a 160-kb fragment while theCRI probe recognizes the 240- and 160-kb fragments .
(h) Fragments generated by Sac II and Sal I . Sequential hybridization employingaMCPprobethat
hybridizes to a 160-kb piece followed by theCRI probe that identifies 240- and 160-kb fragments .
kb. Probes for CRI, CR2, andMCP hybridized to a 550-kb piece andDAF probe
hybridized to a 800-kb piece (not shown) . When the DNA was digested with both
Not I and Mlu I, theDAF probe hybridized to a780-kb fragment (not shown), while600
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the probes for CR1, CR2, and MCP hybridized to a 470-kb fragment (Fig. 1 b) .
These data place the Not I site within the Mlu I fragment . Earlier reports of Rey-
Campos et al. (15) and Carroll et al. (16) have shown that the CRI and CR2 genes
are located on a 450-kb Not I/Mlu I fragment. Thus, our results place the MCP
gene closer to CRl, and CR2 than DAF and C4bp genes.
To localize the gene encoding MCP relative to those for CRl and CR2, DNA
was digested with Sfi I, an enzyme that has previously been shown to separate CR1
and CR2 (15). MCP and CRI probes hybridized with the 380-kb Sfi I fragment
while the CR2 probe hybridized to the 70-kb fragment (Fig. 1 c). Digestion with
Sfi I/Sal I further cleaved the 380-kb Sfi I fragment into 280- and 100-kb pieces.
The CR1 probe recognized the 280-kb fragment, while the MCP probe identified
the 100-kb piece (Fig. 1 d). Since probes for CRI and MCP hybridized to the same
Sfi I restriction fragment and since others have shown that CR1 is oriented 3' to
5' with CR2 next to the 5' end (16), these results indicate that the MCP gene is lo-
cated either on the 3' or 5' end of the CRI gene.
To further define the position ofthe MCP gene relative to CRI, DNA was digested
with Sal I and hybridized to CRI and MCP probes. The CRI probe hybridized
to a 630-kb fragment, while the MCP probe recognized a 180-kb fragment (Fig.
1 e) . A combined digestion of DNA with Sal I and Mlu I decreased the size of the
DNA fragment hybridizing to CRI from 630 to 320 kb, while the MCP probe still
hybridized to the 180-kb restriction fragment (Fig. 1f). CRI, C R2, DAF, and C4bp
probes were previously shown to hybridize to a common Sal I restriction fragment
of -630 kb (15, 16). In our experiments the CR1 probe but not the MCP probe
hybridized to this 630-kb piece. Since MCP and CRI probes hybridized with different
Sal I fragments, we conclude that the MCP gene must be at the 3' end of the CRI
gene. Taken together these data indicate that order of the genes in the RCA gene
cluster is as follows: MCP-CR1-CR2-DAFC4bp (Fig. 2).
Further analysis using Sac II-digested DNA is shown in Fig. 1 g. The MCP probe
hybridized to a 160-kb piece, while the CRI probe hybridized with two pieces of
240 and 160 kb. Using both Sac II/Sal I, the fragments that hybridized to the MCP
and CRI probes were unchanged (Fig. 1 h). Thus these results place the MCP gene
within -100 kb of the 3' end of the CRI gene.
The gene encoding human leukocyte-common antigen (LCA) is also located on
the long arm of chromosome 1 at 1832 (27). However, the leukocyte common an-
tigen probe did not hybridize to the 1,250-kb Not I fragment which in the same set
of experiments was recognized by MCP, CRI, and DAF probes. This observation
indicates that the gene encoding for T200 is not present on the same piece of DNA
as those for MCP, CRI, CR2, DAF, and C4bp.
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Summary
The structural gene for membrane cofactor protein (MCP), a widely distributed
C3b/C4b bindingregulatory glycoprotein ofthe complement system, has beenmapped
to the same locus as the structural genes forCR1, CR2, DAF, and C4bp . The order
of the genes within an -800-kb DNA fragment on the long arm of chromosome
1 is MCP-CR1-CR2-DAFC4bp . Further, theMCP gene maps to within 100 kb of
3' end of the CR1 gene.
We thank Dr.M. L. Thomas, Washington University School of Medicine, for his gift of the
probe for human leukocyte common antigen and Pat Parvin and Lorraine Whiteley for ex-
pert secretarial assistance .
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